Boor P J, Trent M B, Lyles G A, Tao M, Ansari G A
Department of Pathology, University of Texas Medical Branch, Galveston.
Toxicology. 1992;73(3):251-8. doi: 10.1016/0300-483x(92)90067-o.
The capacity of the vascular enzyme, semicarbazide-sensitive amine oxidase (SSAO), to metabolize methylamine to the potentially toxic product, formaldehyde, was tested using rat aortic homogenates and purified porcine aortic SSAO. Formaldehyde production in incubations of enzyme source with methylamine (1 mM) was detected by high performance liquid chromatography and product was confirmed by desorption chemical ionization mass spectrometry (DCI-MS). Inhibitor studies using the specific SSAO inhibitor semicarbazide and the monoamine oxidase inhibitor pargyline indicate that SSAO is responsible for metabolism of methylamine to formaldehyde. These results suggest the possibility that elevated methylamine found in several pathologic states (such as uremia and diabetes mellitus), or generated from exogenous sources, could result in overproduction of formaldehyde in tissues with high SSAO activity, especially blood vessels.
利用大鼠主动脉匀浆和纯化的猪主动脉氨基脲敏感胺氧化酶(SSAO),测试了血管酶SSAO将甲胺代谢为潜在有毒产物甲醛的能力。通过高效液相色谱法检测酶源与甲胺(1 mM)孵育时甲醛的产生,并通过解吸化学电离质谱法(DCI-MS)确认产物。使用特异性SSAO抑制剂氨基脲和单胺氧化酶抑制剂帕吉林进行的抑制剂研究表明,SSAO负责将甲胺代谢为甲醛。这些结果提示,在几种病理状态(如尿毒症和糖尿病)中发现的或由外源性来源产生的甲胺水平升高,可能导致具有高SSAO活性的组织(尤其是血管)中甲醛过度产生。